Saturday, November 4, 2017, 5:00 AM - Sunday, November 5, 2017, 5:00 PM EST, Boston, MA

Modern-day cranioplasty is undergoing a significant paradigm shift related to various techniques, surgical advancements, implantable neurotechnology, and improved biomaterials. These changes have stimulated us to assemble premier thought leaders in various specialties including craniofacial plastic surgery and neurosurgery to meet for the third annual symposium dedicated to the subject of “cranioplasty” and "implantable neurotechnology"— to be hosted this year at Harvard Medical School in Boston, MA. The faculty will gather to present evidence-based data on surgical approaches and state-of-the-art materials, engage and network within a broad array of colleagues and experts, and share high-yield experiences to help attendees improve their patient outcomes. Interactive panel discussions following each lecture will offer the opportunity to debate the evidence, exchange ideas, and gain invaluable insight to assist with the most challenging cases. This year’s symposium will engage an international faculty and audience consisting of craniofacial surgery, neurology, neurosurgery, plastic/reconstructive surgery, oral/maxillofacial surgery, and otolaryngology/head and neck surgery to explore and illucidate the new insights and advances relative to cranioplasty. 

Target Audience
This activity is intended for residents, fellows and physicians in Neurology, Neurosurgery, Craniofacial Surgery, Plastic and Reconstructive Surgery, Otolaryngology—Head and Neck Surgery, Oral Maxillofacial Surgery and Oculoplastic Surgery.

Objectives

After attending this activity, the participant will demonstrate the ability to:

• Create a Cranioplasty reconstruction management plan, from peri to post procedural care.
• Discuss recent advances in Cranioplasty techniques, and how you may incorporate them into your practice.
• Translate Cranioplasty and implantable neurotechnology research findings to improved outcomes based on recent
• evidence-based literature.
• Employ cooperative learning to analyze practice barriers and apply appropriate solutions.

Credit Designation Statement 

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity has been endorsed by the Congress of Neurological Surgeons as relevant to the practice of Neurological Surgery and meets the criteria for Category 1 Neurosurgical Credits as defined by the American Board of Neurological Surgery.

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.